Annual CFO
-$15.95 M
-$2.40 M-17.66%
December 31, 2023
Summary
- As of February 7, 2025, NVCT annual cash flow from operations is -$15.95 million, with the most recent change of -$2.40 million (-17.66%) on December 31, 2023.
- NVCT annual CFO is now -67.87% below its all-time high of -$9.50 million, reached on December 31, 2021.
Performance
NVCT Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$2.40 M
+$616.00 K+20.40%
September 30, 2024
Summary
- As of February 7, 2025, NVCT quarterly cash flow from operations is -$2.40 million, with the most recent change of +$616.00 thousand (+20.40%) on September 30, 2024.
- Over the past year, NVCT quarterly CFO has increased by +$840.00 thousand (+25.89%).
Performance
NVCT Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$13.63 M
+$840.00 K+5.80%
September 30, 2024
Summary
- As of February 7, 2025, NVCT TTM cash flow from operations is -$13.63 million, with the most recent change of +$840.00 thousand (+5.80%) on September 30, 2024.
- Over the past year, NVCT TTM CFO has increased by +$1.99 million (+12.73%).
Performance
NVCT TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
NVCT Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -17.7% | +25.9% | +12.7% |
| 3 y3 years | - | +25.9% | +12.7% |
| 5 y5 years | - | +25.9% | +12.7% |
NVCT Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -67.9% | at low | -125.3% | +49.7% | -43.4% | +18.9% |
| 5 y | 5-year | -67.9% | at low | <-9999.0% | +49.7% | <-9999.0% | +18.9% |
| alltime | all time | -67.9% | at low | <-9999.0% | +49.7% | <-9999.0% | +18.9% |
Nuvectis Pharma Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$2.40 M(-20.4%) | -$13.63 M(-5.8%) |
| Jun 2024 | - | -$3.02 M(-30.7%) | -$14.47 M(-6.8%) |
| Mar 2024 | - | -$4.36 M(+13.2%) | -$15.54 M(-2.6%) |
| Dec 2023 | -$15.95 M(+17.7%) | -$3.85 M(+18.7%) | -$15.95 M(+2.1%) |
| Sep 2023 | - | -$3.24 M(-20.5%) | -$15.62 M(-7.0%) |
| Jun 2023 | - | -$4.08 M(-14.5%) | -$16.80 M(+10.1%) |
| Mar 2023 | - | -$4.78 M(+35.9%) | -$15.26 M(+12.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | -$13.56 M(+42.7%) | -$3.52 M(-20.5%) | -$13.56 M(+22.0%) |
| Sep 2022 | - | -$4.42 M(+74.0%) | -$11.11 M(-0.0%) |
| Jun 2022 | - | -$2.54 M(-17.3%) | -$11.11 M(-11.7%) |
| Mar 2022 | - | -$3.08 M(+188.3%) | -$12.58 M(+32.4%) |
| Dec 2021 | -$9.50 M | -$1.07 M(-75.9%) | -$9.50 M(+12.6%) |
| Sep 2021 | - | -$4.43 M(+10.3%) | -$8.44 M(+110.3%) |
| Jun 2021 | - | -$4.01 M(<-9900.0%) | -$4.01 M(<-9900.0%) |
| Mar 2021 | - | $0.00 | $0.00 |
FAQ
- What is Nuvectis Pharma annual cash flow from operations?
- What is the all time high annual CFO for Nuvectis Pharma?
- What is Nuvectis Pharma annual CFO year-on-year change?
- What is Nuvectis Pharma quarterly cash flow from operations?
- What is the all time high quarterly CFO for Nuvectis Pharma?
- What is Nuvectis Pharma quarterly CFO year-on-year change?
- What is Nuvectis Pharma TTM cash flow from operations?
- What is the all time high TTM CFO for Nuvectis Pharma?
- What is Nuvectis Pharma TTM CFO year-on-year change?
What is Nuvectis Pharma annual cash flow from operations?
The current annual CFO of NVCT is -$15.95 M
What is the all time high annual CFO for Nuvectis Pharma?
Nuvectis Pharma all-time high annual cash flow from operations is -$9.50 M
What is Nuvectis Pharma annual CFO year-on-year change?
Over the past year, NVCT annual cash flow from operations has changed by -$2.40 M (-17.66%)
What is Nuvectis Pharma quarterly cash flow from operations?
The current quarterly CFO of NVCT is -$2.40 M
What is the all time high quarterly CFO for Nuvectis Pharma?
Nuvectis Pharma all-time high quarterly cash flow from operations is $0.00
What is Nuvectis Pharma quarterly CFO year-on-year change?
Over the past year, NVCT quarterly cash flow from operations has changed by +$840.00 K (+25.89%)
What is Nuvectis Pharma TTM cash flow from operations?
The current TTM CFO of NVCT is -$13.63 M
What is the all time high TTM CFO for Nuvectis Pharma?
Nuvectis Pharma all-time high TTM cash flow from operations is $0.00
What is Nuvectis Pharma TTM CFO year-on-year change?
Over the past year, NVCT TTM cash flow from operations has changed by +$1.99 M (+12.73%)